Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

25/03/2025 03:00

Mar 25 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended        Year to  
                  Feb 28, 2025        Feb 29, 2024      May 31, 2025  
                     LATEST             YEAR-AGO           LATEST     
                     RESULTS             RESULTS          FORECAST    
  Sales               46.58               40.67             64.73     
                   (+14.5 pct)         (+5.0 pct)        (+18.9 pct)  
  Operating          95 mln              863 mln           350 mln    
                   (-88.9 pct)         (-3.7 pct)        (-61.8 pct)  
  Recurring        loss 18 mln           799 mln           143 mln    
                                       (-10.2 pct)       (-82.8 pct)  
  Net             loss 272 mln           177 mln        loss 214 mln  
                                       (-15.2 pct)                    
  EPS            loss 24.06 yen         17.22 yen      loss 18.98 yen 
  EPS Diluted                           16.48 yen                     
  Ann Div                               20.00 yen         14.00 yen   
  -Q2 div              NIL                 NIL                        
  -Q4 div                               20.00 yen         14.00 yen   
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T